COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 2609: Articles 26081-26090  | Next

The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study
Leng, T., Whie, C., Hilton, J., Kucharski, A. J., Pellis, L. J., Stage, H., Davies, N. G., Flasche, S. G., Keeling, M. J.
10.1101/2020.06.05.20123448 — Posted: 2020-06-12
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Herroelen, P. H., Martens, G. A., De Smet, D., Swaerts, K., Decavele, A.-S.
10.1101/2020.06.09.20124719 — Posted: 2020-06-12
Predictors of household food insecurity in the United States during the COVID-19 pandemic
Lauren, B. N., Silver, E. R., Faye, A. S., Woo Baidal, J. A., Ozanne, E. M., Hur, C.
10.1101/2020.06.10.20122275 — Posted: 2020-06-12
Clinical outcomes of SARS-CoV-2 pandemic in long-term care facilities for people with epilepsy: observational study
Balestrini, S., Koepp, M. J., Gandhi, S., Rickman, H., Shin, G. Y., Houlihan, C., Anders-Cannon, J., Silvennoinen, K., Xiao, F., Zagaglia, S., Hudgell, K., Ziomek, M., Haimes, P., Sampson, A., Parker, A., Cross, J. H., Pardington, R., Nastouli, E., Swanton, C., Sander, J. W., Sisodiya, S.
10.1101/2020.06.10.20123281 — Posted: 2020-06-12
An imperfect tool: COVID-19 'test & trace' success relies on minimising the impact of false negatives and continuation of physical distancing.
Davis, E. L., Lucas, T. C. D., Borlase, A., Pollington, T. M., Abbott, S., Ayabina, D., Crellen, T., Hellewell, J., Pi, L., Medley, G. F., Hollingsworth, T. D., Klepac, P.
10.1101/2020.06.09.20124008 — Posted: 2020-06-12
Oscillations in USA COVID-19 Incidence and Mortality Data reflect societal factors
Bergman, A., Sella, Y., Agre, P., Casadevall, A.
10.1101/2020.06.08.20123786 — Posted: 2020-06-12
Point of care lung ultrasound is useful when screening for CoVid-19 in Emergency Department patients.
Hankins, A., Bang, H., Walsh, P.
10.1101/2020.06.09.20123836 — Posted: 2020-06-12
Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections.
Rijkers, G., Murk, J.-L., Wintermans, B., van Looy, B., van den Berge, M., Veenemans, J., Stohr, J., Reusken, C., van der Pol, P., Reimerink, J.
10.1101/2020.06.09.20122036 — Posted: 2020-06-12 Discussion: Onsite
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
Giacomelli, A., Pagani, G., Ridolfo, A. L., Oreni, A., Conti, F., Pezzati, L., Bradanini, L., Casalini, G., Passerini, S., Torre, A., Cohen, M., Gubertini, G., Rizzardini, G., Cogliati, C., Ceriani, E., Colombo, R., Rusconi, S., Gervasoni, C., Cattaneo, D., Antinori, S., Galli, M.
10.1101/2020.06.05.20123299 — Posted: 2020-06-12
Evaluation of Sample Pooling for Screening of SARS-CoV-2
Mulu, A., Alemayehu, D. H., Alemu, F., Tefera, D. A., Wolde, S., Aseffa, G., Seyoum, T., Habtamu, M., Abdissa, A., Bayih, A. G., Beyene, G. T.
10.1101/2020.06.10.20123398 — Posted: 2020-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).